IL1B and breast carcinoma: Pro‐inflammatory cytokines such as IL‐1β and TNF‐α further amplify this effect by stimulating both NF‐κB signaling, and ABCG2 expression in certain breast cancer cell lines, suggesting a coordinated response involved in drug resistance [45].